QTRX - Quanterix Corp

QTRX - Quanterix Corp

https://www.quanterix.com

Hold Momentum: Bearish

Recent News

Powered by Alpha Vantage

Down 24.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Quanterix ( QTRX )

Zacks Commentary • 1 month ago • score: 0.22

Quanterix (QTRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Quanterix Corporation ( QTRX ) Reports Q2 Loss, Misses Revenue Estimates

Zacks Commentary • 1 month, 1 week ago • score: 0.04

Quanterix (QTRX) delivered earnings and revenue surprises of -14.63% and -12.62%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Exagen ( XGN ) Soars 5.5%: Is Further Upside Left in the Stock?

Zacks Commentary • 1 month, 3 weeks ago

Exagen (XGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Kent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders - Quanterix ( NASDAQ:QTRX )

Benzinga • 3 months ago • score: 0.02

RINCON, Puerto Rico, June 11, 2025 /PRNewswire/ -- Kent Lake PR LLC ( "Kent Lake" ) , a holder of approximately 6.9% of the outstanding common stock of Quanterix Corporation ( "Quanterix" or the "Company" ) QTRX, today issued the following statement condemning the Company's failure thus far to ...

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal - Akoya Biosciences ( NASDAQ:AKYA ) , Quanterix ( NASDAQ:QTRX )

Benzinga • 3 months, 3 weeks ago • score: 0.12

RINCON, Puerto Rico, May 23, 2025 /PRNewswire/ -- Kent Lake PR LLC ( "Kent Lake" ) , a holder of approximately 6.9% of the outstanding common stock of Quanterix Corporation ( "Quanterix" or the "Company" ) QTRX, today issued the following statement regarding the Company's Post-Effective ...

Quanterix Corporation ( QTRX ) Reports Q1 Loss, Tops Revenue Estimates

Zacks Commentary • 4 months ago • score: -0.04

Quanterix (QTRX) delivered earnings and revenue surprises of 23.19% and 8.99%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Gap ( NYSE:GAP ) , NeoGenomics ( NASDAQ:NEO )

Benzinga • 4 months, 2 weeks ago • score: 0.20

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

As of 2025-09-10 (Snapshot)

Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advance precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the regions from Asia Pacific. The company is headquartered in Billerica, Massachusetts.

52W High

$15.86

52W Low

$4.05

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.03

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-1.49

EV/Revenue (<3 favorable)

0.02

P/S (TTM) (<3 favorable)

1.68

P/B (<3 favorable)

0.72

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

6.46%

Institutions (25–75% balanced)

73.43%

Shares Outstanding

46,465,900

Float

39,871,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

125,784,000

Gross Profit (TTM)

70,038,000

EPS (TTM)

-1.81

Profit Margin (>10% good)

-0.56%

Operating Margin (TTM) (higher better)

-0.86%

ROE (TTM) (>15% strong)

-0.22%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

-0.29

Momentum

Bearish momentum

Value

-0.2008

Previous

-0.2493

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025